Panitumumab in the management of patients with metastatic colorectal cancer – two case reports

05/2018

MUDr. Vít Martin Matějka

Onkologická a radioterapeutická klinika LF UK a FN Plzeň

SUMMARY

These two case studies describe panitumumab in the management of patients with metastatic colorectal carcinoma. There was rapid response in both cases. In the first case report, we describe complete remission of disease after six courses of biochemotherapy. In the second case the patient has recurrence of the disease after surgery. However the treatment continued with panitumumab and time to progression was about two years. Both patients benefited from targeted therapy of panitumumab with a very good quality of life.

KEY WORDS

metastatic colorectal carcinoma, systemic treatment, panitumumab